仙乐健康: 关于调整仙乐转债转股价格的公告

Core Points - The company announced an adjustment to the conversion price of its convertible bonds, reducing it from RMB 42.13 per share to RMB 41.96 per share, effective from March 28, 2025 [1][8] - The adjustment is based on the issuance of new shares and follows the formula outlined in the company's prospectus, which considers the price of new shares and the rate of issuance [1][8] Summary by Sections Conversion Price Adjustment - The previous conversion price was RMB 42.13 per share, which has been adjusted to RMB 41.96 per share [1][8] - The adjustment is triggered by the issuance of new shares under the company's stock incentive plan, which increased the total share capital by 1,401,000 shares, representing a 0.59% increase [5][8] Basis for Adjustment - The adjustment follows the formula: P1 = (P0 + A × k) / (1 + k), where P0 is the previous conversion price, A is the new share price, and k is the issuance rate [1][8] - The new share price for the incentive plan is set at RMB 13.27 per share [5][8] Previous Adjustments - The conversion price has undergone several adjustments in the past due to various corporate actions, including cash distributions and stock grants, with the most recent adjustment prior to this being on June 7, 2023, when it was set at RMB 56.07 per share [4][6][8]